OBJECTIVE: To compare the prevalence, phenotypes, and genes responsible for erythromycin resistance among Streptococcus pyogenes isolates from Mexico and the USA. METHODS: Eighty-nine invasive and 378 non-invasive isolates from Mexico, plus 148 invasive, 21 non-invasive, and five unclassified isolates from the USA were studied. Susceptibilities to penicillin, erythromycin, clindamycin, ceftriaxone, and vancomycin were evaluated according to Clinical and Laboratory Standards Institute (CLSI) standards. Phenotypes of erythromycin resistance were identified by triple disk test, and screening for mefA, ermTR, and ermB genes was carried out by PCR. RESULTS: All isolates were susceptible to penicillin, ceftriaxone, and vancomycin. Erythromycin resistance was found in 4.9% of Mexican strains and 5.2% of USA strains. Phenotypes in Mexican strains were 95% M and 5% cMLS; in strains from the USA, phenotypes were 33.3% iMLS, 33.3% iMLS-D, and 33.3% M. Erythromycin resistance genes in strains from Mexico were mefA (95%) and ermB (5%); USA strains harbored ermTR (56%), mefA (33%), and none (11%). In Mexico, all erythromycin-resistant strains were non-invasive, whereas 89% of strains from the USA were invasive. CONCLUSIONS: Erythromycin resistance continues to exist at low levels in both Mexico and the USA, although the genetic mechanisms responsible differ between the two nations. These genetic differences may be related to the invasive character of the S. pyogenes isolated.
OBJECTIVE: To compare the prevalence, phenotypes, and genes responsible for erythromycin resistance among Streptococcus pyogenes isolates from Mexico and the USA. METHODS: Eighty-nine invasive and 378 non-invasive isolates from Mexico, plus 148 invasive, 21 non-invasive, and five unclassified isolates from the USA were studied. Susceptibilities to penicillin, erythromycin, clindamycin, ceftriaxone, and vancomycin were evaluated according to Clinical and Laboratory Standards Institute (CLSI) standards. Phenotypes of erythromycin resistance were identified by triple disk test, and screening for mefA, ermTR, and ermB genes was carried out by PCR. RESULTS: All isolates were susceptible to penicillin, ceftriaxone, and vancomycin. Erythromycin resistance was found in 4.9% of Mexican strains and 5.2% of USA strains. Phenotypes in Mexican strains were 95% M and 5% cMLS; in strains from the USA, phenotypes were 33.3% iMLS, 33.3% iMLS-D, and 33.3% M. Erythromycin resistance genes in strains from Mexico were mefA (95%) and ermB (5%); USA strains harbored ermTR (56%), mefA (33%), and none (11%). In Mexico, all erythromycin-resistant strains were non-invasive, whereas 89% of strains from the USA were invasive. CONCLUSIONS:Erythromycin resistance continues to exist at low levels in both Mexico and the USA, although the genetic mechanisms responsible differ between the two nations. These genetic differences may be related to the invasive character of the S. pyogenes isolated.
Authors: H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka Journal: N Engl J Med Date: 1992-01-30 Impact factor: 91.245
Authors: D L Horn; J B Zabriskie; R Austrian; P P Cleary; J J Ferretti; V A Fischetti; E Gotschlich; E L Kaplan; M McCarty; S M Opal; R B Roberts; A Tomasz; Y Wachtfogel Journal: Clin Infect Dis Date: 1998-06 Impact factor: 9.079
Authors: P Littauer; D A Caugant; M Sangvik; E A Høiby; A Sundsfjord; G S Simonsen Journal: Antimicrob Agents Chemother Date: 2006-05 Impact factor: 5.191
Authors: E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche Journal: Antimicrob Agents Chemother Date: 2000-06 Impact factor: 5.191
Authors: Michael D Green; Bernard Beall; Mario J Marcon; Coburn H Allen; John S Bradley; Barry Dashefsky; Janet R Gilsdorf; Gordon E Schutze; Clay Smith; Emmanuel B Walter; Judith M Martin; Kathryn M Edwards; Karen A Barbadora; Ellen R Wald Journal: J Antimicrob Chemother Date: 2006-03-23 Impact factor: 5.790
Authors: David F Bruhn; Samanthi L Waidyarachchi; Dora B Madhura; Dimitri Shcherbakov; Zhong Zheng; Jiuyu Liu; Yasser M Abdelrahman; Aman P Singh; Stefan Duscha; Chetan Rathi; Robin B Lee; Robert J Belland; Bernd Meibohm; Jason W Rosch; Erik C Böttger; Richard E Lee Journal: Sci Transl Med Date: 2015-05-20 Impact factor: 17.956
Authors: Neval Akbas; Elizabeth B Draganova; Darci R Block; Brian R Sook; Yau Fong Chan; Joy Zhuo; Zehava Eichenbaum; Kenton R Rodgers; Dabney W Dixon Journal: J Inorg Biochem Date: 2015-11-14 Impact factor: 4.155
Authors: G Gherardi; D Petrelli; M C Di Luca; F Pimentel de Araujo; P Bernaschi; A Repetto; J Bellesi; L A Vitali Journal: Eur J Clin Microbiol Infect Dis Date: 2015-05-30 Impact factor: 3.267
Authors: Wedad Ahmed; Heinrich Neubauer; Herbert Tomaso; Fatma Ibrahim El Hofy; Stefan Monecke; Ashraf Awad Abdeltawab; Helmut Hotzel Journal: Pathogens Date: 2020-05-15